Hong Tran

Managing Associate


Xuan Hong Tran advises companies on a broad range of capital markets transactions, securities law compliance and corporate governance issues with a focus on proxy contests and shareholder activism. 

Hong has served clients in a range of industries such as biopharmaceutical, financial services, technology, energy, and real estate. 

Hong advises pro bono clients on immigration, reproductive justice, climate equity, qualified immunity and veterans law.

  • Selected Transactions

    • Represented Catalyst Biosciences in connection with its reverse merger with GNI group.
    • Represented a life sciences foreign private issuer listed on Nasdaq on its $3.32 million registered direct offering.
    • Represented Eastman Chemical Company in connection with its $800 million sale of tire additives business product lines to One Rock Capital Partners.*
    • Represented Xcel Energy in connection with its $700 million public offering of Senior Notes.*
    • Represented Medifast in connection with a $125 million revolving credit facility.*

    * Matter handled prior to joining Orrick.